KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Emergent BioSolutions (EBS) Total Liabilities (2016 - 2025)

Emergent BioSolutions (EBS) has 16 years of Total Liabilities data on record, last reported at $878.5 million in Q3 2025.

  • For Q3 2025, Total Liabilities fell 9.38% year-over-year to $878.5 million; the TTM value through Sep 2025 reached $878.5 million, down 9.38%, while the annual FY2024 figure was $906.9 million, 22.74% down from the prior year.
  • Total Liabilities reached $878.5 million in Q3 2025 per EBS's latest filing, roughly flat from $880.9 million in the prior quarter.
  • Across five years, Total Liabilities topped out at $1.8 billion in Q4 2022 and bottomed at -$697.2 million in Q3 2023.
  • Average Total Liabilities over 5 years is $948.9 million, with a median of $1.2 billion recorded in 2022.
  • Peak YoY movement for Total Liabilities: plummeted 147.67% in 2023, then surged 328.04% in 2025.
  • A 5-year view of Total Liabilities shows it stood at $1.3 billion in 2021, then skyrocketed by 32.49% to $1.8 billion in 2022, then plummeted by 34.18% to $1.2 billion in 2023, then dropped by 22.74% to $906.9 million in 2024, then decreased by 3.13% to $878.5 million in 2025.
  • Per Business Quant database, its latest 3 readings for Total Liabilities were $878.5 million in Q3 2025, $880.9 million in Q2 2025, and $873.4 million in Q1 2025.